doi:10.16139/j.1007-9610.2018.01.021

[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132.
[2] Chen W, Zheng R, Zuo T, et al.National cancer incidence and mortality in China, 2012[J]. Chin J Cancer Res,2016,28(1):1-11.
[3] Yu W, Whang I, Chung HY, et al.Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial[J]. World J Surg,2001,25(8):985-990.
[4] Fujimoto S, Takahashi M, Mutou T, et al.Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery[J]. Cancer,1997, 79(5):884-891.
[5] Hirose K, Katayama K, Iida A, et al.Efficacy of conti-nuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysis[J]. Oncology,1999,57(2):106-114.
[6] Yonemura Y, Kawamura T, Bandou E, et al.Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion[J]. Br J Surg,2005,92(3):370-375.
[7] Glehen O, Schreiber V, Cotte E, et al.Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer[J]. Arch Surg,2004,139(1):20-26.
[8] Li C, Yan M, Chen J, et al.Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination[J]. J Surg Oncol,2010,102(5):361-365.
[9] Gill RS, Al-Adra DP, Nagendran J, et al.Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity[J]. J Surg Oncol,2011, 104(6):692-698.
[10] Yang XJ, Huang CQ, Suo T, et al.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase Ⅲ randomized clinical trial[J]. Ann Surg Oncol,2011,18(6):1575-1581.
[11] Yuan M, Wang Z, Hu G, et al.A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis[J]. Mol Clin Oncol,2016, 5(2):395-399.
[12] Facchiano E, Risio D, Kianmanesh R, et al.Laparoscopic hyperthermic intraperitoneal chemotherapy: indications, aims, and results: a systematic review of the literature[J]. Ann Surg Oncol,2012,19(9):2946-2950.
[13] Randle RW, Swett KR, Swords DS, et al.Efficacy of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in the management of malignant ascites[J]. Ann Surg Oncol,2014,21(5):1474-1479.
[14] Roviello F, Caruso S, Neri A, et al.Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale[J]. Eur J Surg Oncol,2013,39(12):1309-1316.
[15] Seshadri RA, Glehen O.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer[J]. World J Gastroenterol,2016,22(3):1114-1130.
[16] Polom K, Marano L, Roviello G, et al.Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence[J]. Int J Hyperthermia,2016,32(2):173-179.
[17] Zhu ZG, Tang R, Yan M, et al.Efficacy and safety of intraoperative peritoneal hyperthermic chemotherapy for advanced gastric cancer patients with serosal invasion. A long-term follow-up study[J]. Dig Surg,2006,23(1-2):93-102.
[18] Sun J, Song Y, Wang Z, et al.Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the rando-mized controlled trials[J]. BMC Cancer,2012,12:526.
[19] Mi DH, Li Z, Yang KH, et al.Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials[J]. Int J Hyperthermia,2013,29(2):156-167.
[20] Coccolini F, Cotte E, Glehen O, et al.Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials[J]. Eur J Surg Oncol,2014,40(1):12-26.
[21] 倪震天, 李琛, 严超, 等. 手术联合术中腹腔温热化疗治疗进展期胃癌的疗效及安全性的Meta分析[J]. 中华胃肠外科杂志,2016,19(12):1406-1413.
[22] Fujimura T, Yonemura Y, Nakagawara H, et al.Subtotal peritonectomy with chemohyperthermic peritoneal perfusion for peritonitis carcinomatosa in gastrointestinal cancer[J]. Oncol Rep,2000,7(4):809-814.
[23] Rudloff U, Langan RC, Mullinax JE, et al.Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy(HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial[J]. J Surg Oncol,2014,110(3):275-284.
[24] Mohamed F, Moran BJ.Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve[J]. Cancer J,2009,15(3):196-199.
[25] Pascual-Ramírez J, Sánchez García S, González Ruiz de la Herrán F, et al. Security and efficiency of a closed-system, turbulent-flow circuit for hyperthermic intraperitoneal chemotherapy after cytoreductive ovarian surgery: perioperative outputs[J]. Arch Gynecol Obstet,2014,290(1):121-129.
[26] Raspe C, Piso P, Wiesenack C, et al.Anesthetic management in patients undergoing hyperthermic chemotherapy[J]. Curr Opin Anaesthesiol,2012,25(3):348-355.
[27] Morris DL, Chambers HF, Morris MG, et al.Hemodynamic characteristics of patients with hypothermia due to occult infection and other causes[J]. Ann Intern Med,1985,102(2):153-157.
[28] Passot G, Bakrin N, Isaac S, et al.Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies[J]. Eur J Surg Oncol,2014,40(8):957-962.
[29] Putzu M, Casati A, Berti M, et al.Clinical complications, monitoring and management of perioperative mild hypothermia: anesthesiological features[J]. Acta Biomed,2007,78(3):163-169.
[30] Scott EM, Buckland R. A systematic review of intraoperative warming to prevent postoperative complications[J]. AORN J,2006,83(5):1090-1104, 1107-1113.
[31] Stuart OA, Stephens AD, Welch L, et al.Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C[J]. Ann Surg Oncol,2002,9(2):186-191.
[32] Schmid K, Boettcher MI, Pelz JO, et al.Investigations on safety of hyperthermic intraoperative intraperitoneal chemo-therapy (HIPEC) with Mitomycin C[J]. Eur J Surg Oncol,2006,32(10):1222-1225.
[33] Guerbet M, Goullé JP, Lubrano J.Evaluation of the risk of contamination of surgical personnel by vaporization of oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC)[J]. Eur J Surg Oncol,2007,33(5):623-626.
[34] Konate A, Poupon J, Villa A, et al.Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure[J]. J Surg Oncol,2011,103(1):6-9.
[35] Bharali DJ, Mousa SA.Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise[J]. Pharmacol Ther,2010, 128(2):324-335.
[36] Matano D, Moriwaki T, Tange Y, et al.Successful long-term management with a single administration of tri-weekly nab-paclitaxel in a patient with advanced gastric cancer with peritoneal dissemination[J]. Intern Med,2017, 56(8):921-923.
[37] Frank D, Tyagi C, Tomar L, et al.Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors[J]. Int J Nanomedicine,2014,9:589-613.
[38] Wong BS, Yoong SL, Jagusiak A, et al.Carbon nanotubes for delivery of small molecule drugs[J]. Adv Drug Deliv Rev,2013,65(15):1964-2015.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	DAI Zhiqiang, ZHENG Jinxin, TANG Zhaoqing, ZHANG Qi, GU Yuan, SHI Zhongyi, HU Guohua, SUN Yihong. Metastatic lymph node ratio to evaluate prognosis of patients with stage Ⅱ-Ⅲ gastric cancer after radical gastrectomy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 429-434.
[2]	NIE Mingming, ZHU Zhenggang. Clinical significance of diagnostic laparoscopy on precision staging in advanced gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 365-370.
[3]	GUO Liangqi, YAN Zhilong, ZHANG Moucheng. Laparoscopic intragastric surgery in treating of gastric submucosal tumor and early gastric cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(04): 380-383.
[4]	LU Weihui, LIU Wei, WANG Cong, WANG Zhenglin. Effects of CXCR2 on invasion, migration and apoptosis of gastric cancer cells [J]. Journal of Surgery Concepts & Practice, 2021, 26(5): 430-436.
[5]	LIU Jingzheng, REN Zhong, HU Jianwei, QIN Wenzheng, ZHONG Yunshi, ZHOU Pinghong. Clinical effect of endoscopic full thickness resection in treatment of small gastric submucosal tumors [J]. Journal of Surgery Concepts & Practice, 2021, 26(03): 236-239.
[6]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 1-6.
[7]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 11-16.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 17-20.
[9]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 28-33.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 38-40.
[11]	YANG Zhongyin, LI Chen, LIU Wentao, SHI Min, WU Junwei, ZHENG Yanan, ZHU Zhenglun, HUA Zichen, NI Zhentian, LU Sheng, YAN Min, YAN Chao, ZHU Zhenggang. Complications of implanted subcutaneous port for intraperitoneal chemotherapy in gastric cancer patients with peritoneal metastasis and analysis of risk factors of complications [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 41-47.
[12]	LI Mei, QIU Wencai, GAO Qi, YANG Jun, JIA Zhenyi. Perioperative application of geriatric nutritional risk index in senile patients with gastrointestinal tumors [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 58-61.
[13]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 76-78.
[14]	. [J]. Journal of Surgery Concepts & Practice, 2021, 26(01): 79-83.
[15]	. [J]. Journal of Surgery Concepts & Practice, 2020, 25(04): 341-343.